Evaluation of Clinical Outcomes of Icotinib in Patients With Clinically Diagnosed Advanced Lung Cancer With EGFR-Sensitizing Variants Assessed by Circulating Tumor DNA Testing: A Phase 2 Nonrandomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2022.2719
Abstract: Importance The inability to obtain a pathological diagnosis in a certain proportion of patients with clinically diagnosed advanced lung cancer impedes precision treatment in clinical practice. Objective To evaluate the clinical outcome of first-line icotinib… read more here.
Keywords: lung cancer; trial; lung; diagnosed advanced ... See more keywords
Etiologies of delayed diagnosis and six‐month outcome of patients with newly diagnosed advanced lung cancer with respiratory failure at initial presentation
Sign Up to like & getrecommendations! Published in 2020 at "Thoracic Cancer"
DOI: 10.1111/1759-7714.13604
Abstract: This study aimed to evaluate the characteristics of patients with newly diagnosed advanced lung cancer who initially presented with respiratory failure. read more here.
Keywords: advanced lung; patients newly; newly diagnosed; diagnosed advanced ... See more keywords
Racial differences in patterns of treatment among men first diagnosed with advanced prostate cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e16527
Abstract: e16527Background: A small proportion of men (~4%) are newly-diagnosed with advanced stage prostate cancer (PCa) and experience poorer survival compared to men diagnosed with local or regionally-adv... read more here.
Keywords: differences patterns; diagnosed advanced; prostate cancer; racial differences ... See more keywords
PARP Inhibitors in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Meta-Analysis of Randomized Clinical Trials
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.01204
Abstract: Background: The efficacy of poly(adenosine diphosphate–ribose) polymerase inhibitors (PARPi) as a maintenance therapy in patients with newly diagnosed advanced ovarian cancer remains unclear. We conducted a meta-analysis to assess the benefits and safety of PARPi… read more here.
Keywords: patients newly; newly diagnosed; diagnosed advanced; ovarian cancer ... See more keywords